GlassScriptPhysician profile
Roger A Kasendorf
NPI 1356371884
$32,389.60
in general payments reported to CMS, 2019-2025
55 companies · $894 in 2025
The $894 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $1,441 · 2021: $5,664 · 2022: $4,128 · 2023: $1,075 · 2024: $906 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,874.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $13,783.43 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $4,048.33 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $2,987.19 | 2022 | |
| West Therapeutics Development, LLC | $2,512.24 | 2019 | |
| Collegium Pharmaceutical, INC. | $1,324.96 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $1,098.19 | 2021-2025 | |
| Biodelivery Sciences International, INC. | $559.33 | 2019-2021 | |
| Electronic Waveform Lab, INC. | $492.89 | 2019-2025 | |
| Arbor Pharmaceuticals, INC. | $432.08 | 2019-2022 | |
| Pfizer INC. | $408.45 | 2019-2025 | |
| Zyla Life Sciences, INC. | $396.94 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $377.98 | 2019-2024 | |
| Lilly USA, LLC | $311.35 | 2019-2024 | Reyvow, Emgality |
| Almatica Pharma LLC | $242.99 | 2021-2023 | Gralise |
| Takeda Pharmaceuticals U.S.A., INC. | $234.66 | 2019-2020 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Kasendorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.